scholarly article | Q13442814 |
P356 | DOI | 10.1093/CVR/25.5.391 |
P953 | full work available at URL | http://academic.oup.com/cardiovascres/article-pdf/25/5/391/949311/25-5-391.pdf |
P698 | PubMed publication ID | 1855244 |
P2093 | author name string | P. Braquet | |
M. Koltai | |||
A. Esanu | |||
A. Tosaki | |||
D. Hosford | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Cardiology and cardiovascular medicine | Q96320350 |
physiology | Q521 | ||
P304 | page(s) | 391-397 | |
P577 | publication date | 1991-05-01 | |
P1433 | published in | Cardiovascular Research | Q4642329 |
P1476 | title | Effect of BN 50739, a new platelet activating factor antagonist, on ischaemia induced ventricular arrhythmias in isolated working rat hearts | |
P478 | volume | 25 |
Q52353228 | Do platelets promote cardiac recovery post myocardial infarction: Roles beyond occlusive ischemic damage. |
Q42089750 | Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits |
Q43205546 | Involvement of A pertussis Toxin Sensitive G-Protein in the Inhibition of Inwardly Rectifying K Currents by Platelet-Activating Factor in Guinea-Pig Atrial Cardiomyocytes |
Q79879935 | Left regional cardiac perfusion in vitro with platelet-activating factor, norepinephrine and K+ reveals that ischaemic arrhythmias are caused by independent effects of endogenous "mediators" facilitated by interactions, and moderated by paradoxical |
Q41594309 | Nupafant, a PAF-antagonist prototype for suppression of ventricular fibrillation without liability for QT prolongation? |
Q34875121 | Oxidative stress and neutrophil activation--the two keystones of ischemia/reperfusion injury. |
Q28609461 | PAF. A review of its effects, antagonists and possible future clinical implications (Part II) |
Q40524595 | Platelet activating factor antagonists |
Q40695898 | Polymorphonuclear leukocytes in ischemic vascular disease. |
Q33933810 | Reperfusion injury after focal myocardial ischaemia: polymorphonuclear leukocyte activation and its clinical implications |
Search more.